awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35906490-9EC04628-8CEA-4C97-9D81-2038C3442FE8
Q35906490-9EC04628-8CEA-4C97-9D81-2038C3442FE8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35906490-9EC04628-8CEA-4C97-9D81-2038C3442FE8
SGLT-2 Inhibitors: A New Mechanism for Glycemic Control.
P2860
Q35906490-9EC04628-8CEA-4C97-9D81-2038C3442FE8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35906490-9EC04628-8CEA-4C97-9D81-2038C3442FE8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1831fcf81f3c1e217fd2deabd1c3f0384f1bc54f
P2860
Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial.